Paragon 28, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Paragon 28, Inc. | FNA - NYSE |
$15.00-$17.00 | $16.00 | $19.15 | 7.8 million | 10/15/2021 |
| BofA Securities, Piper Sandler | ||||||
Co-Manager(s): Canaccord Genuity, JMP Securities, Needham & Co. | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-09-24 Terms Added 2021-10-08 | ||||||
Paragon 28, Inc. Quote & Chart - Click for current quote - FNA
IPO Boutique aggregates information on public companies and private companies, such as "FNA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Paragon 28, Inc. (adapted from Paragon 28, Inc. prospectus):
They are a leading medical device company exclusively focused on the foot and ankle orthopedic market and we are dedicated to improving patient lives.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a leading medical device company exclusively focused on the foot and ankle orthopedic market and we are dedicated to improving patient lives.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "FNA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.